Comparison of Ivabradine and Beta-blockers Administration in the Treatment of Inappropriate Sinus Tachycardia

Trial Profile

Comparison of Ivabradine and Beta-blockers Administration in the Treatment of Inappropriate Sinus Tachycardia

Completed
Phase of Trial: Phase III

Latest Information Update: 04 Oct 2016

At a glance

  • Drugs Ivabradine (Primary) ; Bisoprolol
  • Indications Sinus tachycardia
  • Focus Therapeutic Use
  • Acronyms CIBIST
  • Most Recent Events

    • 29 Sep 2016 Status changed from recruiting to completed.
    • 09 Nov 2015 Planned End Date changed from 1 Jun 2016 to 1 Dec 2016 as per ClinicalTrials.gov record.
    • 04 Nov 2015 Planned End Date changed from 1 Dec 2014 to 1 Jun 2016 as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top